Welcome to our dedicated page for Quipt Home Medical news (Ticker: QIPT), a resource for investors and traders seeking the latest updates and insights on Quipt Home Medical stock.
Quipt Home Medical Corp. operated as a U.S.-based home medical equipment provider focused on end-to-end respiratory care, in-home monitoring and disease management services for the U.S. healthcare market. Company updates centered on respiratory solutions, resupply activity, chronic disease management offerings, operating and financial results, capital-structure disclosure, governance matters and shareholder voting.
Quipt's later news documented the completed plan of arrangement through which all outstanding common shares were acquired for cash by a purchaser funded by affiliates of Kingswood Capital Management and Forager Capital Management. The completed transaction changed the public-company status of the former Nasdaq and TSX-listed QIPT common shares.
Quipt Home Medical Corp., a U.S.-based home medical equipment provider, has announced a normal course issuer bid (NCIB) to repurchase up to 3,626,845 common shares, representing about 10% of its public float. The NCIB will start on May 6, 2024, and end by April 30, 2025, or when the maximum shares are repurchased. The company believes its shares are undervalued and sees this as an opportunity to enhance shareholder value.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.